Drugmakers Must Decide Whether to Negotiate: Timeline Explained

Manufacturers of the first 10 drugs up for Medicare price negotiations now have about a month to decide whether to participate or pull all of their products from the federal health insurance program.

The Centers for Medicare & Medicaid Services on Tuesday unveiled its long-awaited list of Medicare Part D prescription drugs subject to price-lowering talks with the agency under the Inflation Reduction Act. Affected drugmakers have until Oct. 1 to sign agreements to negotiate with the CMS over the first round of price cuts, which would go into effect in 2026.

The companies must submit manufacturer-specific data, including information ...